Tandem Diabetes Care, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10.3M | 136 | 49.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9.2M | 18,469 | 44.3% |
| Food and Beverage | $925,725 | 32,715 | 4.4% |
| Travel and Lodging | $161,002 | 236 | 0.8% |
| Consulting Fee | $127,987 | 93 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $70,605 | 100 | 0.3% |
| Charitable Contribution | $2,000 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP) | $2.6M | 0 | 17 |
| Investigational Extended Wear Insulin Infuion Set During Home Use in People with Type 1 Diabetes (CapBio_Steadiset) | $1.9M | 0 | 14 |
| A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy | $888,117 | 0 | 18 |
| Control-IQ 2.0 Feasibility Study #2: Use of Control-IQ Technology 2.0 in Adults, Children and Preschoolers with Type 1 Diabetes | $540,437 | 0 | 4 |
| A Control-IQ 2.0 Feasibility Study in Adult and Adolescent Subjects | $459,918 | 0 | 3 |
| Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes with AID Use | $326,420 | 0 | 9 |
| Control-IQ Technology for High Insulin Users with Type 1 Diabetes | $291,421 | 0 | 4 |
| Ancillary Study to Test Control-IQ System with Meal Bolus and Exercise Challenges | $141,519 | 0 | 1 |
| t:slim X2 insulin pump with Control-IQ technology US Post-Approval Study | $138,829 | 0 | 22 |
| Use of a Hybrid Closed Loop Insulin Delivery System in a High Risk Type 1 Diabetes Population | $109,559 | 0 | 2 |
| Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes | $26,396 | 0 | 3 |
| Cardiovascular Health with T1D | $20,403 | 0 | 2 |
| Control-IQ 1.5 Post Approval Study (CLIO Mini) | $15,168 | 0 | 1 |
| Adolescent Physiology and Psychology Longitudinal Evaluation | $4,272 | 0 | 3 |
| Early Adoption of Tech | $1,100 | 0 | 1 |
| Breaking Health Care Disparities in Access to Advanced Diabetes Tech in Children with T1D | $950.30 | 0 | 2 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Dr. Fred Cohen, M.d, M.D | Internal Medicine | San Francisco, CA | $983,381 | $0 |
| Jordan Pinsker, M.d, M.D | Pediatric Endocrinology | Santa Barbara, CA | $73,404 | $0 |
| Jasbir Dhawan, Md, MD | Internal Medicine | Frisco, TX | $42,851 | $0 |
| Lee Metchick, Md, MD | Endocrinology, Diabetes & Metabolism | Deland, FL | $38,274 | $0 |
| Michael Swinyard, Md, MD | Pediatric Endocrinology | South Jordan, UT | $36,734 | $0 |
| Joann Ahern, Aprn, APRN | Medical-Surgical | Danbury, CT | $33,998 | $0 |
| Dr. Steven Leichter, M.d, M.D | Endocrinology, Diabetes & Metabolism | Columbus, GA | $29,331 | $0 |
| Dr. Bennett Baquet, M.d, M.D | Endocrinology, Diabetes & Metabolism | Lafayette, LA | $29,016 | $0 |
| Dr. Rocio Harbison, Md, MD | Endocrinology, Diabetes & Metabolism | Houston, TX | $28,720 | $0 |
| Dr. Bethany Jackson, M.d, M.D | Endocrinology, Diabetes & Metabolism | Florence, AL | $27,083 | $0 |
| Mary Jane Mcdevitt, Rn,Msn,Crnp,Cde, RN,MSN,CRNP,CDE | Nurse Practitioner | Springfield, PA | $26,288 | $0 |
| Dr. Shreya Parikh, M.d, M.D | Endocrinology, Diabetes & Metabolism | Sugar Land, TX | $25,669 | $0 |
| Thomas Jones, Md, MD | Endocrinology, Diabetes & Metabolism | Macon, GA | $25,608 | $0 |
| Dr. Jennifer Rittenberry, M.d, M.D | Endocrinology, Diabetes & Metabolism | Dublin, OH | $24,822 | $0 |
| Pallavy Reddy, Md, MD | Endocrinology, Diabetes & Metabolism | Dublin, OH | $22,912 | $0 |
| Victor Roberts, M.d, M.D | Endocrinology, Diabetes & Metabolism | Lake Mary, FL | $20,950 | $0 |
| Mary Sullivan, Dnp, Fnp, Rn, DNP, FNP, RN | Primary Care | Germantown, TN | $20,411 | $0 |
| Dr. Julia Warren-Ulanch, Md, MD | Endocrinology, Diabetes & Metabolism | Raleigh, NC | $20,158 | $0 |
| David Okubo, M.d, M.D | Hospice and Palliative Medicine | West Jordan, UT | $19,077 | $0 |
| Dr. William Debell, M.d, M.D | Endocrinology, Diabetes & Metabolism | Tuscaloosa, AL | $18,841 | $0 |
| Annette Haynes, Np, NP | Family | New Ulm, MN | $17,496 | $0 |
| Dr. Justin Fontenot, Md, MD | Endocrinology, Diabetes & Metabolism | Lafayette, LA | $16,602 | $0 |
| Jerome Fischer, Md, MD | Endocrinology, Diabetes & Metabolism | San Antonio, TX | $16,272 | $0 |
| Ms. Andrea Hayes, M.d, M.D | Specialist | Nashville, TN | $16,002 | $0 |
| Kathleen Arnold, A.n.p, A.N.P | Adult Health | Ocean Springs, MS | $15,583 | $0 |
Top Products
- t:slim X2 Insulin Pump with Control-IQ $11.1M
- t-slim insulin pump $5.9M
Associated Products (3)
- t:slim X2 Insulin Pump with Control-IQ $11.1M
- t-slim insulin pump $5.9M
- t:slim X2 insulin pump $3.9M
Payment Categories
- Food & Beverage $925,725
- Consulting $127,987
- Travel & Lodging $161,002
- Research $10.3M
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. has made $20.9M in payments to 8,907 healthcare providers, recorded across 51,750 transactions in the CMS Open Payments database. In 2024, the company paid $5.9M. The top product by payment volume is t:slim X2 Insulin Pump with Control-IQ ($11.1M).
Payments were distributed across 136 medical specialties. The top specialty by payment amount is Endocrinology, Diabetes & Metabolism ($1.4M to 2,709 doctors).
Payment categories include: Food & Beverage ($925,725), Consulting ($127,987), Research ($10.3M), Travel & Lodging ($161,002).
Tandem Diabetes Care, Inc. is associated with 3 products in the CMS Open Payments database.